Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial

BACKGROUND: Recently, long-acting injection (LAI) of second-generation antipsychotics has become a valuable strategy for the treatment of schizophrenia. However, few studies have compared the effects of different LAI antipsychotics on cognitive functions so far. The present study aimed to compare th...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Psychiatry
Päätekijät: Takekita, Yoshiteru, Koshikawa, Yosuke, Fabbri, Chiara, Sakai, Shiho, Sunada, Naotaka, Onohara, Ai, Nishida, Keiichiro, Yoshimura, Masafumi, Kato, Masaki, Serretti, Alessandro, Kinoshita, Toshihiko
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2016
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4884618/
https://ncbi.nlm.nih.gov/pubmed/27236412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-016-0883-9
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia